FAU and Torrey Pines Institute for Molecular Studies (TPIMS) have finalized a cooperative agreement to enter into a research and educational partnership. This signed agreement implements a plan in which Torrey Pines scientists and FAU faculty, staff and students work jointly and cooperatively on planned educational and research activities of mutual interest.
“FAU is pleased to enter into an agreement with Torrey Pines that will not only allow for advances in scientific research, but will promote the education and training of students, faculty and researchers to meet scientific challenges,” said President Brogan. “Collaboration with educational and research institutes such as Torrey Pines assists FAU in its mission to enhance economic, human and cultural development.”
The cooperative agreement, which includes a tangible in-kind commitment of approximately $6.5 million, finalizes a proposal from FAU to provide 15,000 square feet of research and laboratory space in FAU’s joint-use facility at the Harbor Branch Oceanographic Institution to TPIMS on a temporary basis until its permanent facilities are constructed in Port St. Lucie. In addition, the agreement provides for joint-faculty appointments, graduate student support, affiliate faculty appointments and access to state-of-the-art instrumentation.
“Torrey Pines is very excited to be working closely with FAU on a wide range of highly positive scientific collaborations,” said Dr. Richard Houghten, president of TPIMS. “In the many years to come, we envision significant collaborative scientific and medical advances over a wide range of areas. The joint scientific work by these two entities is part of what will make the Torrey Pines branch in Florida so exciting.”
Torrey Pines is an internationally recognized research organization focused on conducting basic biomedical research and drug discovery of vaccines, treatments and cures for leading causes of human disease and suffering, including multiple sclerosis, cancer, heart disease, infectious diseases, Alzheimer’s disease, chronic pain, inflammation, transplant rejection and aging-related conditions.